| 摘要 |
<p>The present invention provides human TSC-22-like proteins HT22L1 and HT22L2 polynucleotides which encode HT22L1 and HT22L2. The invention also provides expression vectors, host cells, agonists, antisense molecules, antibodies, or antagonists. The invention also provides methods for treating disorders associated with expression of HT22L1 and HT22L2.</p> |
